VANHAUDENHUYSE, Audrey ; Centre Hospitalier Universitaire de Liège - CHU > Département d'Anesthésie et réanimation > Centre interdisciplinaire d'algologie
CHICHE, Laurent
STAVRIS, Chloe
BENANNI, Myriam
FAYMONVILLE, Marie-Elisabeth ; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service d'oncologie médicale
ALITTA, Anouk
Language :
English
Title :
Hypnotherapy in Treatment of Mastocytosis: a prospective study
Publication date :
2021
Journal title :
International Journal of Clinical and Experimental Hypnosis
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S., de Haes, J., Kaasa, S., Klee, M., Osoba, D., Razavi, D., Rofe, P. B., Schraub, S., Sneeuw, K., Sullivan, M., & Takeda, F., (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85 (5), 365–376. https://doi.org/10.1093/jnci/85.5.365
Aich, A., Afrin, L. B., & Gupta, K. (2015). Mast cell-mediated mechanisms of nociception. International Journal of Molecular Sciences, 16 (12), 29069–29092. https://doi.org/10.3390/ijms161226151
Bandeen-Roche, K., Seplaki, C. L., Huang, J., Buta, B., Kalyani, R. R., Varadhan, R., Xue, Q. L., Walston, J. D., & Kasper, J. (2015). Frailty in older adults: A nationally representative profile in the United States. Journals of Gerontology - Series A Biological Sciences and Medical Sciences, 70 (11), 1427–1434. https://doi.org/10.1093/gerona/glv133
Barete, S. (2014). Les mastocytoses [Mastocytosis]. Annales de Dermatologie et de Vénéréologie, 141 (11), 698–714. https://doi.org/10.1016/j.annder.2014.08.002
Bernardy, K., Füber, N., Klose, P., & Häuser, W. (2011). Efficacy of hypnosis/guided imagery in fibromyalgia syndrome–a systematic review and meta-analysis of controlled trials. BMC Musculoskeletal Disorders, 12 (133), 1–11. https://doi.org/10.1186/1471-2474-12-133
Boddaert, N., Salvador, A., Chandesris, M. O., Lemaître, H., Grévent, D., Gauthier, C., Naggara, O., Georgin-Lavialle, S., Moura, D. S., Munsch, F., Jaafari, N., Zilbovicius, M., Lortholary, O., Gaillard, R., & Hermine, O. (2017). Neuroimaging evidence of brain abnormalities in mastocytosis. Translational Psychiatry, 7 (8), e1197. https://doi.org/10.1038/tp.2017.137
Bodemer., C., Hermine, O., Palmérini, F., Yang, Y., Grandpeix-Guyodo, C., Leventhal, P. S., Hadj-Rabia, S., Nasca, L., Georgin-Lavialle, S., Cohen-Akenine, A., Launay, J. M., Barete, S., Feger, F., Arock, M., Catteau, B., Sans, B., Stalder, J. F., Skowron, F., Thomas, L., Lorette, G., & Dubreuil, P. (2010). Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations. Journal of Investigative Dermatology, 130 (3), 804–815. https://doi.org/10.1038/jid.2009.281
Boonstra, A. M., Preuper, H., Reneman, M., Posthumus, J., & Stewart, R. (2008). Reliability and validity of the visual analogue scale for disability in patients with chronic musculoskeletal pain. International Journal of Rehabilitation Research, 31 (2), 165–169. https://doi.org/10.1097/MRR.0b013e3282fc0f93
Chen, P. Y., Liu, Y. M., & Chen, M. L. (2017). The effect of hypnosis on anxiety in patients with cancer: A meta-analysis. Worldviews on Evidence-Based Nursing, 14 (3), 223–236. https://doi.org/10.1111/wvn.12215
Colloca, L., & Barsky, A. (2020). Placebo and nocebo effects. New England Journal of Medicine, 382 (6), 554–561. https://doi.org/10.1056/NEJMra1907805
Elkins, G. R., Barabasz, A., Council, J., & Speigel, D. (2015). Advancing research and practice: The revised APA Division 30 definition of hypnosis. International Journal of Clinical and Experimental Hypnosis, 63 (1), 1–9. https://doi.org/10.1080/00207144.2014.961870
Flik, C. E., Laan, W., Zuithoff, N. P., Van Rood, Y. R., Smout, A. J., Weusten, B. L., Whorwell, P. J., & De Wit, N. J. (2019). Efficacy of individual and group hypnotherapy in irritable bowel syndrome (IMAGINE): A multicentre randomized controlled trial. Lancet Gastroenterology and Hepatology, 4 (1), 20–31. https://doi.org/10.1016/S2468-1253(18)30310-8
Ford, A. C., Lacy, B. E., Harris, L. A., Quigley, E. M., & Moayyedi, P. (2019). Effect of antidepressants and psychological therapies in irritable bowel syndrome: An updated systematic review and meta-analysis. American Journal of Gastroenterology, 114 (1), 21–39. https://doi.org/10.1038/s41395-018-0222-5
Frisaldi, E., Shaibani, A., & Benedetti, F. (2020). Understanding the mechanisms of placebo and nocebo effects. Swiss Medical Weekly, 1 (150), w20340. https://doi.org/10.4414/smw.2020.20340
Georgin-Lavialle, S., Barete, S., Suarez, F., Lepelletier, Y., Bodemer, C., Dubreuil, P., Lortholary, O., & Hermine, O. (2009). Actualités sur la compréhension et le traitement des mastocytoses systémiques [Current concepts and treatment advances in systemic mastocytosis]. Revue De Medecine Interne, 30 (1), 25–34. https://doi.org/10.1016/j.revmed.2008.01.025
Georgin-Lavialle, S., Moura, D. S., Bruneau, J., Chauvet-Gélinier, J. C., Damaj, G., Soucie, E., Barete, S., Gacon, A. L., Grandpeix-Guyodo, C., Suarez, F., Launay, J. M., Durieu, I., Esparcieux, A., Guichard, I., Sparsa, A., Nicolini, F., de Gennes, C., Trojak, B., Haffen, E., Vandel, P., & Hermine, O. (2014, January). Leukocyte telomere length in mastocytosis: Correlations with depression and perceived stress. Brain, Behavior, and Immunity, 35, 51–57. https://doi.org/10.1016/j.bbi.2013.07.009
Georgin-Lavialle, S., Moura, D. S., Salvador, A., Chauvet-Gelinier, J. C., Launay., J. M., Damaj, G., Côté, F., Soucié, F., Chandesris, M. O., Barète, S., Grandpeix-Guyodo, C., Bachmeyer, C., lyanakian, M. A., Aouba, A., Lortholary, O., Dubreuil, P., Teyssier, J. R., Trojak, B., Haffen, E., Vandel, P., Bonin, B., the French Mast Cell Study Group, Hermine, O., & Gaillard, R. (2016). Mast cells’ involvement in inflammation pathways linked to depression: Evidence in mastocytosis. Molecular Psychiatry, 21 (11), 1511–1516. https://doi.org/10.1038/mp.2015.216
Gupta, K., & Harvima, I. T. (2018). Mast cell-neural interactions contribute to pain and itch. Immunological Reviews, 282 (1), 168–187. https://doi.org/10.1111/imr.12622
Hermans, M. A., Arends, N. J., Gerth van Wijk, R., Van Hagen, P. M., Kluin-Nelemans, H. C., Oude Elberink, H. N., Pasmans, S. G., & van Daele, P. (2017). Management around invasive procedures in mastocytosis: An update. Annals of Allergy, Asthma and Immunology, 119 (4), 304–309. https://doi.org/10.1016/j.anai.2017.07.022
Hermine, O., Lortholary, O., Leventhal, P. S., Catteau, A., Soppelsa, F., Baude, C., Cohen-Akenine, A., Palmerini, F., Hanssens, K., Yang, Y., Sobol, H., Fraytag, S., Ghez, D., Suarez, F., Barete, S., Casassus, P., Sans, B., Arock, M., Kinet, J. P., Dubreuil, P., & Moussy, A. (2008). Case-control cohort study of patients’ perceptions of disability in mastocytosis. PLoS One, 3 (5), e2266. https://doi.org/10.1371/journal.pone.0002266
Jennings, S., Russell, N., Jennings, B., Slee, V., Sterling, L., Castells, M., Valent, P., & Akin, C. (2014). The mastocytosis society survey on mast cell disorders: Patient experiences and perceptions. Journal of Allergy and Clinical Immunology: In Practice, 2 (1), 70–76. https://doi.org/10.1016/j.jaip.2013.09.004
Lee, H. H., Choi, Y. Y., & Choi, M. G. (2014). The efficacy of hypnotherapy in the treatment of irritable bowel syndrome: A systematic review and meta-analysis. Journal of Neurogastroenterology and Motility, 20 (2), 152–162. https://doi.org/10.5056/jnm.2014.20.2.152
Marrache, F., Mémain, N., Bonté, I., Barete, S., Casassus, P., de Gennes, C., Fain, O., Lortholary, O., & Hermine, O. (2003). Treatment of systemic mastocytosis. Revue De Medecine Interne, 24 (9), 594–601. https://doi.org/10.1016/s0248-8663(03)00141-3
Molderings, G. J., Haenisch, B., Brettner, S., Homann, J., Menzen, M., Dumoulin, F. L., Panse, J., Butterfield, J., & Afrin, L. A. (2016). Pharmacological treatment options for mast cell activation disease. Naunyn-Schmiedeberg’s Archives of Pharmacology, 389 (7), 671–694. https://doi.org/10.1007/s00210-016-1247-1
Moura, D. S., Georgin-Lavialle, S., Gaillard, R., & Hermine, O. (2014). Neuropsychological features of adult mastocytosis. Immunology and Allergy Clinics of North America, 34 (2), 407–422. https://doi.org/10.1016/j.iac.2014.02.001
Moura, D. S., Sultan, S., Georgin-Lavialle, S., Barete, S., Lortholary, O., Gaillard, R., & Hermine, O. (2012). Evidence for cognitive impairment in mastocytosis: Prevalence, features and correlations to depression. PLoS One, 7 (6), e39468. https://doi.org/10.1371/journal.pone.0039468
Nunns, M., Mayhew, D., Ford, T., Rogers, M., Curle, C., Logan, S., & Moore, D. (2018). Effectiveness of nonpharmacological interventions to reduce procedural anxiety in children and adolescents undergoing treatment for cancer: A systematic review and meta-analysis. Psycho-Oncology, 27 (8), 1889–1899. https://doi.org/10.1002/pon.4749
Omdal, R., Skoie, I. M., & Grimstad, T. (2018, Mar-Dec). Fatigue is common and severe in patients with mastocytosis. International Journal of Immunopathology and Pharmacology, 32, 1–4. https://doi.org/10.1177/2058738418803252
Onnes, M., Tanno, L., & Oude Elberink, J. (2016). Mast cell clonal disorders: Classification, diagnosis and management. Current Treatment Options in Allergy, 3 (4), 453–464. https://doi.org/10.1007/s40521-016-0103-3
Pardanani, A. (2016). Systemic mastocytosis in adults: 2017 update on diagnosis, risk stratification and management. American Journal of Hematology, 91 (11), 1146–1159. https://doi.org/10.1002/ajh.24553.
Pardanani, A., Lim, K. H., Lasho, T. L., Finke, C. M., McClure, R. F., Li, C. Y., & Tefferi, A. (2010). WHO subvariants of indolent mastocytosis: Clinical details and prognostic evaluation in 159 consecutive adults. Blood, 115 (1), 150–151. https://doi.org/10.1182/blood-2009-10-249979
Rampakakis, E., Ste-Marie, P. A., Sampalis, J. S., Karellis, A., Shir, Y., & Fitzcharles, M. A. (2015). Real-life assessment of the validity of patient global impression of change in fibromyalgia. RMD Open, 1 (1), e000146. https://doi.org/10.1136/rmdopen-2015-000146
Rossignol, J., Polivka, L., Maouche-Chrétien, L., Frenzel, L., Dubreuil, P., & Hermine, O. (2019). Recent advances in the understanding and therapeutic management of mastocytosis. F1000 Research, 8 (F1000 Faculty Rev), 1961. https://doi.org/10.12688/f1000research.19463.1
Schaefert, R., Klose, P., Moser, G., & Häuser, W. (2014). Efficacy, tolerability, and safety of hypnosis in adult irritable bowel syndrome: Systematic review and meta-analysis. Psychosomatic Medicine, 76 (5), 389–398. https://doi.org/10.1097/PSY.0000000000000039
Tao, W. W., Tao, X. M., & Song, C. L. (2017). Effects of non-pharmacological supportive care for hot flushes in breast cancer: A meta-analysis. Supportive Care in Cancer, 25 (7), 2335–2347. https://doi.org/10.1007/s00520-017-3691-y
Theoharides, T. C., Tsilioni, I., & Bawazeer, M. (2019, August 2). Mast cells, neuroinflammation and pain in Fibromyalgia Syndrome. Frontiers in Cellular Neuroscience, 13, 353. https://doi.org/10.3389/fncel.2019.00353
Thia, K., Faubion, W., Loftus, E., Persson, T., Persson, A., & Sandborn, W. (2011). Short CDAI: Development and validation of a shortened and simplified Crohn’s Disease Activity Index. Inflammatory Bowel Diseases, 17 (1), 105–111. https://doi.org/10.1002/ibd.21400.
Thompson, T., Terhune, D. B., Oram, C., Sharangparni, J., Rouf, R., Solmi, M., Veronese, N., & Stubbs, B. (2019, April). The effectiveness of hypnosis for pain relief: A systematic review and meta-analysis of 85 controlled experimental trials. Neuroscience & Biobehavioral Reviews, 99, 298–310. https://doi.org/10.1016/j.neubiorev.2019.02.013
Travis, W. D., Li, C. Y., Bergstralh, E. J., Yam, L. T., & Swee, R. G. (1988). Systemic mast cell disease. Analysis of 58 cases and literature review. Medicine (Baltimore), 67 (6), 345–368. https://doi.org/10.1097/00005792-198811000-00001
Uranga, J. A., Martínez, V., & Abalo, R. (2020). Mast cell regulation and irritable Bowel Syndrome: Effects of food components with potential nutraceutical use. Molecules, 25 (18), 4314. https://doi.org/10.3390/molecules25184314.
Valent, P., Akin, C., Arock, M., Brockow, K., Butterfield, J. H., Carter, M. C., Castells, M., Escribano, L., Hartmann, K., Lieberman, P., Nedoszytko, B., Orfao, A., Schwartz, L., Sotlar, K., Sperr, W. R., Triggiani, M., Valenta, R., Horny, H. P., & Metcalfe, D. D. (2012). Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: A consensus proposal. International Archives of Allergy and Immunology, 157 (3), 215–225. https://doi.org/10.1159/000328760.
Valent, P., Akin, C., & Metcalfe, D. D. (2017). Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts. Blood, 129 (11), 1420–1427. https://doi.org/10.1182/blood-2016-09-731893
Valent., P., Akin, C., Gleixner, K. V., Sperr, W. R., Reiter, A., Arock, M., & Triggiani, M. (2019). Multidisciplinary challenges in mastocytosis and how to address with personalized medicine approaches. International Journal of Molecular Sciences, 20 (12), 2976. https://doi.org/10.3390/ijms20122976
Van Anrooij, B., Kluin-Nelemans, J. C., Safy, M., Flokstra-de Blok, B. M., & Oude Elberink, J. N. (2016). Patient-reported disease-specific quality-of-life and symptom severity in systemic mastocytosis. Allergy, 71 (11), 1585–1593. https://doi.org/10.1111/all.12920
Vanhaudenhuyse, A., Gillet, A., Malaise, N., Salamun, I., Barsics, C., Grosdent, S., Maquet, D., Nyssen, A. S., & Faymonville, M. E. (2015). Efficacy and cost-effectiveness: A study of different treatment approaches in a tertiary pain centre. European Journal of Pain, 19 (10), 1437–1446. https://doi.org/10.1002/ejp.674
Zech, N., Hansen, E., Bernardy, K., & Häuser, W. (2017). Efficacy, acceptability and safety of guided imagery/hypnosis in fibromyalgia - A systematic review and meta-analysis of randomized controlled trials. European Journal of Pain, 21 (2), 217–227. https://doi.org/10.1002/ejp.933
